| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/19/1985 | CA1182811A1 Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for its obtention and its applications |
| 02/19/1985 | CA1182753A1 Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells |
| 02/19/1985 | CA1182748A1 Method for synthesizing procoagulant factor viii activity |
| 02/14/1985 | WO1985000607A1 Antibiotic tan-542 and process for its preparation |
| 02/14/1985 | WO1985000521A1 Enzyme derivatives |
| 02/13/1985 | EP0133029A2 A process for producing inhibiting agents against proliferation of malignant tumour cells, and agents produced thereby |
| 02/13/1985 | EP0132981A2 Hypotriglyceridemically active polysaccharides |
| 02/13/1985 | EP0132979A2 Aqueous atelocollagen solution and method of preparing same |
| 02/13/1985 | EP0132655A2 Enzymatic conversion of certain sub-type A and AB erythrocytes |
| 02/12/1985 | US4499080 Synthetic ST toxin, process for its preparation and its use as a vaccinating agent |
| 02/12/1985 | CA1182395A1 Stable, base serum compositions and preparation thereof |
| 02/05/1985 | US4497797 β-Galactosidase inhibitor GT-2558 and its derivatives |
| 02/05/1985 | CA1182047A1 Process for the production of blood-clotting factors and preparation of factors ix and x, prepared by this process |
| 01/30/1985 | EP0132349A2 Antibiotic called "chloropolysporin", a process for its preparation, and its therapeutic and veterinary use |
| 01/29/1985 | US4496689 Pulmonary emphysema therapy |
| 01/29/1985 | US4496544 Smooth muscle relaxants and diuretics |
| 01/29/1985 | CA1181703A1 Immunostimulating preparations based on ribosomal rna's and a process for the preparation of the rna's |
| 01/29/1985 | CA1181690A1 Gastric antacid and method for controlling ph of gastric juice |
| 01/23/1985 | EP0132178A1 Process for the preparation of the principal proteins of hemolysed blood in a non denatured form |
| 01/23/1985 | EP0132125A2 A protein having antitumor activity |
| 01/23/1985 | EP0132118A2 Antibiotics produced by Kibdelosporangium aridum Shearer gen. nov., sp. nov. ATCC 39323 |
| 01/23/1985 | EP0132116A2 The aglycone and pseudo-aglycones of the AAD 216 antibiotics |
| 01/23/1985 | EP0132082A2 Antibiotic/antitumor compounds and their production |
| 01/23/1985 | EP0132021A1 TGF polypeptides, antigenic oligopeptides derived therefrom and antibodies produced therefrom |
| 01/23/1985 | EP0131843A1 Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods |
| 01/23/1985 | EP0131789A2 Composition comprising purified human tumour necrosis factor in conjunction with human interferon and its use |
| 01/23/1985 | EP0131740A2 Undenatured virus-free biologically active protein derivatives |
| 01/22/1985 | US4495358 Antibiotic pyrrolomycin E |
| 01/22/1985 | US4495175 Preparation of highly purified human antihemophilic factor |
| 01/22/1985 | US4495096 Process for producing and obtaining anaphylatoxin-and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form |
| 01/22/1985 | CA1181343A1 Sterilized, preserved, stable mucine-containing solutions and methods for their preparation |
| 01/22/1985 | CA1181206A1 Hollow fibre membrane for plasma separation |
| 01/16/1985 | EP0131552A2 Purified seminal antigenic fraction, process for its preparation and use of said fraction for the dosage of the spermagglutinating antibodies |
| 01/16/1985 | EP0131150A2 Purification and characterization of a fibroblast growth factor |
| 01/15/1985 | US4493845 Antibiotic AM-3603 |
| 01/15/1985 | US4493829 Bio-available succinylated protein-iron derivatives which do not cause gastric lesions, method of preparation and related pharmaceutical compounds |
| 01/15/1985 | US4493826 Gentamicin-gleptoferron compositions |
| 01/15/1985 | CA1181006A1 Therapeutic agent for treating respiratory diseases |
| 01/09/1985 | EP0130898A1 Product constituted by a polymer or a copolymer comprising in its chain groups presenting an affinity vis-à-vis the thrombine, process for its manufacture and its use in the separation and purification of the thrombine |
| 01/09/1985 | EP0130554A1 Novel, physiologically active substance, process for production thereof and pharmaceutical composition containing the same |
| 01/08/1985 | CA1180699A1 Ganglioside derivatives, preparation process and application thereof |
| 01/03/1985 | WO1985000043A1 Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
| 01/03/1985 | WO1985000042A1 Process for growing human epidermis, product and use thereof |
| 01/02/1985 | EP0129877A2 Novel antibiotic SF-2288 and its preparation method |
| 01/02/1985 | EP0129696A1 Method and reagent for the direct detection of an analyte in aqueous solutions of biological origin after specific removal of colloid particles |
| 01/02/1985 | EP0129669A2 An estrogen receptor assay and test kit therefor |
| 01/01/1985 | US4491660 Matrix polymers for binding endotoxins |
| 12/27/1984 | EP0129534A2 Process for the preparation of an antithrombin III-heparin, e.g. an antithrombin III-heparinoid concentrate |
| 12/27/1984 | EP0129431A2 A therapeutically useful mineral composition |
| 12/25/1984 | US4490361 Virus inactivating heat treatment of plasma fractions |
| 12/25/1984 | US4490359 Bacillus sibtilis containing feeds for rabbits, minks and sheep |
| 12/20/1984 | WO1984004887A1 A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A gamma-INTERFERON CONTAINING PREPARATION |
| 12/20/1984 | WO1984004885A1 Compositions for cosmetic, health- and body-preserving use |
| 12/20/1984 | WO1984004870A1 Stabilization of neutrophils and platelets |
| 12/19/1984 | EP0128733A1 Human insulin-like growth factor (IGF) produced from a recombinant host, process, expression vector and recombinant host therefor, and IGF-containing pharmaceutical composition |
| 12/19/1984 | EP0128233A1 Process for preparing products having a specific composition from mineral and medicinal water |
| 12/19/1984 | EP0128205A1 Activated, stabilized enzymes useful for wound healing |
| 12/18/1984 | US4489163 rCRF and analogs |
| 12/18/1984 | US4489162 Fresh blood (unfixed) hematology control |
| 12/18/1984 | US4489066 Arterial polysaccharide complex, a method for its preparation and composition comprising same |
| 12/18/1984 | US4489060 Method of solidifying bile |
| 12/18/1984 | US4489059 Anorexigenic composition and method |
| 12/18/1984 | US4488969 Fibrous media containing millimicron-sized particulates |
| 12/12/1984 | EP0128097A1 Immunostiumulating derivatives, their preparation and their use as medicines |
| 12/12/1984 | EP0128041A2 Polypeptides exhibiting skeletal growth factor activity |
| 12/11/1984 | US4487766 Lignin, carbonization, basification, acidification, antimetabolic, trace elements |
| 12/11/1984 | US4487762 Antibiotic 5057B substance |
| 12/11/1984 | US4487700 Method and apparatus for separating lymphocytes from anticoagulated blood |
| 12/11/1984 | CA1179277A1 Blood purification device |
| 12/11/1984 | CA1179265A1 Bifidobacteria-proliferating agent |
| 12/06/1984 | WO1984004817A1 Method and reagent for the direct detection of an analyte after the specific elimination of colloidal particles in aqueous solutions of biological origin |
| 12/06/1984 | WO1984004675A1 Vaginal capsules |
| 12/05/1984 | EP0127605A2 Process for obtaining preparations of human blood plasma |
| 12/05/1984 | EP0127603A2 Process for the preparation of a composition containing a factor VIII(AHF) |
| 12/05/1984 | EP0127394A2 Mutant human T cell lines producing immunosuppressive factor and method for obtaining such mutants |
| 12/05/1984 | EP0127358A2 Method and composition for isolating white cell elements |
| 12/05/1984 | EP0127305A1 Human growth hormone, and process for its production, expression vehicles for producing pre HGH and host cells transformed thereby |
| 12/04/1984 | US4486414 Antileukemia |
| 12/04/1984 | US4486410 Antihemophilic factor |
| 12/04/1984 | US4486341 Continuous, multistage |
| 12/04/1984 | CA1178887A1 Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique |
| 11/28/1984 | EP0126544A2 Phenylalanine hydroxylase cDNA clones, their methods of production and use in diagnosing classical phenylketonuria |
| 11/28/1984 | EP0126351A1 Process for the isolation and purification of antibiotics |
| 11/28/1984 | EP0126344A2 Tripeptide esters of therapeutic agents |
| 11/27/1984 | US4485100 Polypeptides; antishock, antiinflammatory and emphysemia treatment |
| 11/27/1984 | US4485098 Iodine-enriched eggs |
| 11/27/1984 | US4485040 Ultrafiltration with molecular weight cut-off membrane |
| 11/22/1984 | WO1984004457A1 Alpha-lactalbumin contraceptive |
| 11/21/1984 | EP0125892A2 Islets-activating protein derivatives |
| 11/21/1984 | EP0125514A2 Membrane-associated placenta protein (MP1), process for obtaining it and its use |
| 11/21/1984 | EP0059182B1 A process for isolating aminoacylase enzyme from a mammal kidney extract |
| 11/20/1984 | CA1178227A1 Antibiotic a/16686 factor a.sub.2, the process for the preparation thereof and the co-produced antibiotic a/16686 factors a.sub.1 and a.sub.3 |
| 11/20/1984 | CA1178200A1 Method of treating inflammation using bovine milk |
| 11/14/1984 | EP0125125A2 An agent for inhibiting the proliferation of malignant tumour cells and a process for the preparation thereof |
| 11/14/1984 | EP0124984A1 Marine organism extracts and their preparation |
| 11/14/1984 | EP0124896A1 Process for obtaining viruses or virusantigens and use thereof in diagnosis and therapy (vaccine) |
| 11/14/1984 | EP0124665A1 Dermatological compositions |
| 11/14/1984 | EP0124613A1 Novel plasminogen activator derived from human kidneys, process for its preparation, and thrombolytic drug containing the same |
| 11/14/1984 | EP0124579A1 Magnetic separation using chelated magnetic ions |
| 11/13/1984 | US4482543 Biologically active substance, process for preparing the substance and immunoactive composition |